Investigation of JC Virus Positivity By Real-time Polymerase Chain Reaction in Patients with Hematopoietic Stem Cell Transplant

Introduction: In immunocompromised hosts, JC virus (JCV) can reactivate and cause a lytic infection of oligodendrocytes, resulting in progressive multifocal leukoencephalopathy (PML). Bone marrow is an important reservoir and possible site of neurotropic transformation for JCV. The aim of this retro...

Full description

Bibliographic Details
Main Authors: Meryem ÇOLAK, Aylin ALTAY KOÇAK, Lale AYDIN KAYNAR, Zübeyde Nur ÖZKURT, Zeynep Arzu YEĞİN, Gülendam BOZDAYI
Format: Article
Language:English
Published: Bilimsel Tip Yayinevi 2020-03-01
Series:Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
Subjects:
Online Access:http://www.floradergisi.org/getFileContent.aspx?op=REDPDF&file_name=2020-25-01-040-046.pdf
_version_ 1797922620460498944
author Meryem ÇOLAK
Aylin ALTAY KOÇAK
Lale AYDIN KAYNAR
Zübeyde Nur ÖZKURT
Zeynep Arzu YEĞİN
Gülendam BOZDAYI
author_facet Meryem ÇOLAK
Aylin ALTAY KOÇAK
Lale AYDIN KAYNAR
Zübeyde Nur ÖZKURT
Zeynep Arzu YEĞİN
Gülendam BOZDAYI
author_sort Meryem ÇOLAK
collection DOAJ
description Introduction: In immunocompromised hosts, JC virus (JCV) can reactivate and cause a lytic infection of oligodendrocytes, resulting in progressive multifocal leukoencephalopathy (PML). Bone marrow is an important reservoir and possible site of neurotropic transformation for JCV. The aim of this retrospective study was to investigate the prevalance of JCV infection by real-time polymerase chain reaction (PCR) in patients sent from bone marrow transplant service to the laboratory in our hospital. Materials and Methods: A total of 153 clinical samples obtained from 62 patients with hematopoietic stem cell transplant between December 2013 and April 2018 were included into the study. Viral nucleic acids were extracted from the samples with QIAamp DSP Virus Kit in EZ1 Advanced (Qiagen, Germany) device. Isolated viral DNA was amplified with Real Star® JCV PCR Kit in Rotor-GeneQ (Altona, Germany) and JCV DNA was detected with qualitative method. Results: Sixty-two patients, 35 (56.5%) males and 27 (43.5%) females, between 18 years and 71 years of age were included into the study. Total JCV DNA positivity rate was found as 11.1% (17/153). Patients’ diagnosis was respectively as follows: 45.2% acute myeloid leukemia, 19.4% acute lymphoblastic leukemia, 9.7% multiple myeloma. 6.4% myeloblastic sendrome, 6.4% non-Hodgkin lymphoma, 6.4% Hodgkin lymphoma, and 6.4% anemia. The distribution of JCV DNA positivity rates was found respectively as 40% acute myeloid leukemia, 30% multiple myeloma, 10% Hodgkin lymphoma, 10% acute lymphoblastic leukemia and 10% Non-hodgkin lymphoma. It was observed that 50% of JCV DNA positive patients died in the follow-up period after hematopoietic stem cell transplantation. Conclusion: It is not possible to diagnose JCV infections clinically because they are usually asymptomatic. However, up to 90% of those diagnosed with PML die within the first six months receiving a diagnosis. Detection and clinical surveillance JCV DNA by real-time PCR for hematopoietic stem cell transplantation patients is important for early diagnosis and treatment.
first_indexed 2024-04-10T14:34:11Z
format Article
id doaj.art-c0f4aaa13ad04aa1b8ae30bc00603008
institution Directory Open Access Journal
issn 1300-932X
1308-5115
language English
last_indexed 2024-04-10T14:34:11Z
publishDate 2020-03-01
publisher Bilimsel Tip Yayinevi
record_format Article
series Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
spelling doaj.art-c0f4aaa13ad04aa1b8ae30bc006030082023-02-15T16:08:40ZengBilimsel Tip YayineviFlora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi1300-932X1308-51152020-03-01251404610.5578/flora.68466Investigation of JC Virus Positivity By Real-time Polymerase Chain Reaction in Patients with Hematopoietic Stem Cell TransplantMeryem ÇOLAK0https://orcid.org/0000-0001-9876-935XAylin ALTAY KOÇAK1https://orcid.org/0000-0002-0451-0142Lale AYDIN KAYNAR2https://orcid.org/0000-0003-1539-077XZübeyde Nur ÖZKURT3https://orcid.org/0000-0001-9834-6058Zeynep Arzu YEĞİN4https://orcid.org/0000-0002-0212-9663Gülendam BOZDAYI5https://orcid.org/0000-0002-6036-6819Department of Medical Microbiology, Faculty of Medicine, University of Karabuk, Karabuk, TurkeyDepartment of Medical Microbiology, Faculty of Medicine, University of Baskent, Ankara, TurkeyDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Gazi, Ankara, TurkeyDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Gazi, Ankara, TurkeyDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, University of Gazi, Ankara, TurkeyDepartment of Medical Microbiology, Faculty of Medicine, University of Gazi, Ankara, TurkeyIntroduction: In immunocompromised hosts, JC virus (JCV) can reactivate and cause a lytic infection of oligodendrocytes, resulting in progressive multifocal leukoencephalopathy (PML). Bone marrow is an important reservoir and possible site of neurotropic transformation for JCV. The aim of this retrospective study was to investigate the prevalance of JCV infection by real-time polymerase chain reaction (PCR) in patients sent from bone marrow transplant service to the laboratory in our hospital. Materials and Methods: A total of 153 clinical samples obtained from 62 patients with hematopoietic stem cell transplant between December 2013 and April 2018 were included into the study. Viral nucleic acids were extracted from the samples with QIAamp DSP Virus Kit in EZ1 Advanced (Qiagen, Germany) device. Isolated viral DNA was amplified with Real Star® JCV PCR Kit in Rotor-GeneQ (Altona, Germany) and JCV DNA was detected with qualitative method. Results: Sixty-two patients, 35 (56.5%) males and 27 (43.5%) females, between 18 years and 71 years of age were included into the study. Total JCV DNA positivity rate was found as 11.1% (17/153). Patients’ diagnosis was respectively as follows: 45.2% acute myeloid leukemia, 19.4% acute lymphoblastic leukemia, 9.7% multiple myeloma. 6.4% myeloblastic sendrome, 6.4% non-Hodgkin lymphoma, 6.4% Hodgkin lymphoma, and 6.4% anemia. The distribution of JCV DNA positivity rates was found respectively as 40% acute myeloid leukemia, 30% multiple myeloma, 10% Hodgkin lymphoma, 10% acute lymphoblastic leukemia and 10% Non-hodgkin lymphoma. It was observed that 50% of JCV DNA positive patients died in the follow-up period after hematopoietic stem cell transplantation. Conclusion: It is not possible to diagnose JCV infections clinically because they are usually asymptomatic. However, up to 90% of those diagnosed with PML die within the first six months receiving a diagnosis. Detection and clinical surveillance JCV DNA by real-time PCR for hematopoietic stem cell transplantation patients is important for early diagnosis and treatment.http://www.floradergisi.org/getFileContent.aspx?op=REDPDF&file_name=2020-25-01-040-046.pdfjc virusimmunosuppressive patienthematopoietic stem cell transplantreal-time polimerase chain reaction
spellingShingle Meryem ÇOLAK
Aylin ALTAY KOÇAK
Lale AYDIN KAYNAR
Zübeyde Nur ÖZKURT
Zeynep Arzu YEĞİN
Gülendam BOZDAYI
Investigation of JC Virus Positivity By Real-time Polymerase Chain Reaction in Patients with Hematopoietic Stem Cell Transplant
Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
jc virus
immunosuppressive patient
hematopoietic stem cell transplant
real-time polimerase chain reaction
title Investigation of JC Virus Positivity By Real-time Polymerase Chain Reaction in Patients with Hematopoietic Stem Cell Transplant
title_full Investigation of JC Virus Positivity By Real-time Polymerase Chain Reaction in Patients with Hematopoietic Stem Cell Transplant
title_fullStr Investigation of JC Virus Positivity By Real-time Polymerase Chain Reaction in Patients with Hematopoietic Stem Cell Transplant
title_full_unstemmed Investigation of JC Virus Positivity By Real-time Polymerase Chain Reaction in Patients with Hematopoietic Stem Cell Transplant
title_short Investigation of JC Virus Positivity By Real-time Polymerase Chain Reaction in Patients with Hematopoietic Stem Cell Transplant
title_sort investigation of jc virus positivity by real time polymerase chain reaction in patients with hematopoietic stem cell transplant
topic jc virus
immunosuppressive patient
hematopoietic stem cell transplant
real-time polimerase chain reaction
url http://www.floradergisi.org/getFileContent.aspx?op=REDPDF&file_name=2020-25-01-040-046.pdf
work_keys_str_mv AT meryemcolak investigationofjcviruspositivitybyrealtimepolymerasechainreactioninpatientswithhematopoieticstemcelltransplant
AT aylinaltaykocak investigationofjcviruspositivitybyrealtimepolymerasechainreactioninpatientswithhematopoieticstemcelltransplant
AT laleaydinkaynar investigationofjcviruspositivitybyrealtimepolymerasechainreactioninpatientswithhematopoieticstemcelltransplant
AT zubeydenurozkurt investigationofjcviruspositivitybyrealtimepolymerasechainreactioninpatientswithhematopoieticstemcelltransplant
AT zeyneparzuyegin investigationofjcviruspositivitybyrealtimepolymerasechainreactioninpatientswithhematopoieticstemcelltransplant
AT gulendambozdayi investigationofjcviruspositivitybyrealtimepolymerasechainreactioninpatientswithhematopoieticstemcelltransplant